Division of Translational Medical Oncology

The Division of Translational Medical Oncology, established in 2019, has two overarching goals. First, investigators in the laboratory use functional and structural genetic approaches to gain insights into cancer biology that can be translated into novel diagnostic and therapeutic strategies. Second, clinically oriented investigators are working within prospective programs to generate comprehensive molecular portraits of large numbers of human cancers and use the results to inform clinical action – both at the level of individual patients and in the context of academically initiated trials – while feeding results back into exploratory research projects aimed at improving functional and mechanistic understanding of cancers. In keeping with these forward- and reverse-translational efforts at the interface between experimental cancer research and clinical application, which have a particular focus on the large and underserved group of rare cancers, the division's researchers represent multiple career paths and stages (postdoctoral scientists, Ph.D., M.Sc., and B.Sc. students; oncologists and M.D. students) and are supported by research technicians, study nurses, documentation staff, and dedicated administrative, data management, and scientific coordination teams.